Shares of Novavax NVAX are higher on the session by 17.26%, currently trading at $1.97. The stock has been moving largely lower over the past three months, but it is currently trading above the 50-day moving average.
Options traders are focusing on calls today. A short while ago the April 2012 $2.00 call traded 600 times on open interest of 8 contracts.
Calls are outpacing puts today by 50 to 1.
Novavax, Inc. is a biopharmaceutical company focused on developing recombinant vaccines. The company's technology platform is based on the virus-like particles.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in